Last reviewed · How we verify

IDP-124 Vehicle Lotion

Bausch Health Americas, Inc. · Phase 3 active Small molecule

IDP-124 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect.

IDP-124 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect. Used for Dermatological conditions requiring topical treatment (specific indication not publicly disclosed).

At a glance

Generic nameIDP-124 Vehicle Lotion
SponsorBausch Health Americas, Inc.
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

IDP-124 Vehicle Lotion is a dermatological formulation that serves as a delivery system for topical agents. As a vehicle lotion in phase 3 development by Bausch Health, it is designed to optimize skin penetration and therapeutic efficacy of active ingredients while maintaining tolerability and cosmetic acceptability for topical application.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: